🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI
$3.05
+1.50% 1Y
Mkt Cap$33.84M
P/E-5.65
P/B1.15
52W High$6.08
52W Low$2.37
Book Value$2.64
EPS (TTM)$-0.54

Company Overview

PPSI (PPSI) is a publicly traded company listed on with a market capitalization of $33.84M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.05.

Recent Developments

  • Dec 2025 Revenue of $27.63M (+20.8% YoY); net profit $-6.00M.
  • Trailing 12 Months Year-on-year growth — revenue +20.8%, earnings -118.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR -3.8%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-3.76%
1 Year:20.75%

Compounded Profit Growth

5 Years:-
1 Year:-118.83%

Stock Price Performance

1 Year:+1.50%
6 Months:-33.26%
3 Months:-28.24%
1 Month:-14.57%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 18% of range
$2.37 $6.08
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • Death Cross2d ago
  • RSI (14)39.99 · Neutral
Price Performance
1M-14.57%
3M-28.24%
6M-33.26%
1Y+1.50%

Auto-generated from price history and fundamentals; not investment advice.

Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Revenue declined at -3.8% CAGR over 5 years.
  • Trading 49.8% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Ad space

Valuation

Stock P/E
-5.65
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$2.64
Price to Book
1.15
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-3.76%
Profit 5Y
-
Revenue (YoY)
20.75%
Earnings (YoY)
-118.83%

Profitability & Returns

ROCE
-21.57%
ROE
-20.46%
ROA
-16.92%
Profit Margin
-21.71%
Op Margin
-23.87%
Gross Margin
12.40%
EPS (Latest Qtr)
$-0.23
EPS (TTM)
$-0.54

Balance Sheet & Liquidity

Debt/Equity
0.05
Quick Ratio
3.94
Current Ratio
5.23
Debt
$1.50M
Total Assets
$33.02M
Current Assets
$23.73M
Working Capital
$20.66M

Ownership

Promoter Holding
22.50%
Chg in Prom Hold
0.00%
FII / Inst Holding
9.33%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$27.63M
EBITDA
$-5.20M
Free Cash Flow
$-8.49M
Operating Cash Flow
$-5.82M
Shares Outstanding
11.10M
Gross Margin
12.40%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue --------------------5.09M4.05M3.50M5.62M5.68M6.34M4.83M6.37M9.55M12.28M11.45M3.31M3.40M6.42M-6.74M8.37M6.89M5.63M4.27M
Cost of Revenue -----------------------------------6.59M7.06M6.25M4.30M3.68M
Gross Profit 5.90M4.92M4.19M6.71M5.57M5.07M5.04M5.86M6.27M6.52M5.57M5.82M5.01M5.18M193.00K597.00K256.00K521.00K256.00K177.00K-297.00K739.00K159.00K495.00K713.00K-888.00K-1.23M2.17M2.83M3.88M3.70M535.00K641.00K1.52M-148.00K1.31M640.00K1.32M582.00K
Operating Expenses -----------------------------------2.49M3.02M2.09M2.42M2.60M
Operating Income 2.29M995.00K571.00K2.81M-84.00K-687.00K-3.33M1.09M1.38M1.21M1.13M1.85M1.05M281.00K-1.56M-1.17M-1.44M-1.55M-3.59M-1.75M-1.18M-451.00K-1.11M-745.00K-518.00K-2.63M-3.81M-131.00K675.00K789.00K940.00K-1.73M-1.74M-714.00K--2.35M-1.71M-1.45M-1.09M-2.02M
EBITDA ------------------------------------2.01M-1.35M-1.12M-723.00K-1.66M
Interest Expense ----------------------------------------
Pretax Income ------------------------------------2.08M-1.23M-1.70M-1.37M-2.51M
Tax Provision -----------------------------------0069.00K5.00K0
Net Income 1.01M590.00K302.00K1.78M-225.00K-817.00K-3.55M569.00K194.00K322.00K109.00K1.28M-795.00K-574.00K-796.00K58.00K5.65M-4.02M6.99M-2.92M-660.00K1.34M351.00K-686.00K-434.00K-2.55M-3.83M2.00K742.00K848.00K1.01M-1.03M-2.28M-1.12M--929.00K-1.33M-2.35M-1.39M-2.51M
Diluted EPS 0.170.080.040.25-0.03-0.11-0.480.070.020.040.010.15-0.09-0.07-0.090.010.65-0.460.80-0.33-0.080.150.04-0.08-0.05-0.26-0.390.000.070.080.10-0.10-0.21-0.10--0.09-0.12-0.21--0.23
R&D Expense -------------------------------211.00K238.00K256.00K-80.00K534.00K111.00K-156.00K

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 47.24M68.79M83.96M88.16M92.19M106.52M99.63M114.39M20.13M20.58M19.49M-25.88M11.12M22.88M27.63M
Cost of Revenue ------------23.05M8.89M17.36M24.20M
Gross Profit 11.60M15.98M18.94M21.77M18.17M21.44M22.15M17.74M1.89M1.17M881.00K-2.83M2.23M5.51M3.43M
Operating Expenses ------------8.64M9.26M10.76M10.02M
Operating Income 4.10M4.71M5.95M7.13M1.75M-5.30M3.56M-3.31M-9.12M-11.75M-4.28M--5.81M-7.04M-5.25M-6.59M
EBITDA -------------4.68M-5.62M-4.18M-5.20M
Interest Expense ----------------
Pretax Income -------------5.41M-6.28M-4.77M-6.37M
Tax Provision ------------7.00K0-1.42M74.00K
Net Income 2.95M-60.00K2.99M5.27M-268.00K-5.88M-1.06M-9.22M-5.66M-1.03M-2.99M--5.42M-1.90M31.86M-6.00M
Diluted EPS 0.50-0.010.510.84-0.04-0.76-0.12-1.06-0.65-0.12-0.34--0.37-0.202.90-0.54
R&D Expense -------------885.00K1.05M875.00K

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Mar 2020Dec 2020Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Dec 2024Dec 2025
Total Assets -32.10M48.84M52.18M53.86M72.84M66.88M77.41M74.25M72.51M28.48M-21.29M-32.92M30.20M27.60M35.39M34.61M31.00M35.70M33.02M65.95M35.45M
Current Assets -----------------31.25M---27.68M56.66M25.54M
Cash & Equivalents 1.56M516.00K1.40M467.00K425.00K3.83M648.00K246.00K218.00K211.00K8.21M-7.57M----10.30M---3.58M41.62M14.96M
Inventory -----------------8.09M---3.08M6.07M6.32M
Receivables -----------------10.01M---1.22M7.83M3.13M
Total Liabilities -17.01M34.07M34.26M23.07M42.00M39.48M51.21M56.71M60.56M11.64M-7.43M-15.84M16.30M13.54M20.24M18.59M13.31M17.21M18.80M30.52M6.14M
Current Liabilities -14.38M21.18M20.64M12.35M24.26M38.10M43.74M46.75M52.42M9.84M8.70M5.54M-14.42M14.86M12.24M18.96M17.53M12.48M16.56M18.26M29.98M4.88M
Long Term Debt ----7.21M9.54M165.00K4.00M4.15M2.62M--633.00K-----------
Total Debt -----------------2.27M---869.00K775.00K1.50M
Total Equity 9.61M15.09M14.77M17.91M30.79M30.83M27.39M26.20M17.55M11.95M16.84M13.92M13.86M-17.07M13.91M14.05M15.15M16.02M17.69M18.49M14.22M35.43M29.32M
Shares Outstanding -----------------9.64M---9.93M11.12M11.10M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 3.31M1.60M2.41M3.22M95.00K-3.96M-9.46M1.70M2.15M-5.57M-3.61M--5.77M-3.90M-6.21M-5.82M
Investing Cash Flow -2.31M-9.49M-2.37M-4.32M-1.81M-3.40M-618.00K-1.43M173.00K39.77M2.63M-4.72M-2.50M38.88M-3.90M
Financing Cash Flow -2.04M8.76M-1.04M1.22M5.72M4.52M9.96M642.00K-3.41M-26.23M337.00K--353.00K-323.00K5.38M-16.95M
Capital Expenditure --1.36M-2.07M-2.69M-723.00K-1.05M-668.00K-1.45M-589.00K-153.00K---1.51M-2.50M-3.76M-2.68M
Free Cash Flow -237.00K339.00K525.00K-628.00K-5.01M-10.13M250.00K1.56M-5.73M---7.28M-6.39M-9.97M-8.49M
Net Change in Cash -------------1.40M-6.71M38.04M-26.66M
Dividends Paid -----------1.05M---16.66M

Ratios (Annual)

Figures in %.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 24.6%23.2%22.6%24.7%19.7%20.1%22.2%15.5%9.4%5.7%4.5%-10.9%20.0%24.1%12.4%
Operating Margin % 8.7%6.8%7.1%8.1%1.9%-5.0%3.6%-2.9%-45.3%-57.1%-22.0%--22.5%-63.3%-22.9%-23.9%
Net Margin % 6.2%-0.1%3.6%6.0%-0.3%-5.5%-1.1%-8.1%-28.1%-5.0%-15.3%--20.9%-17.1%139.2%-21.7%
ROE % 19.5%-0.4%16.7%17.1%-0.9%-21.5%-4.1%-52.6%-47.4%-6.1%-21.5%--35.8%-13.3%89.9%-20.5%
ROCE % 23.1%17.0%18.9%17.2%3.6%-18.4%10.6%-12.0%-45.4%-63.1%-27.2%--35.4%-47.7%-14.6%-21.6%

Shareholding Pattern

Insiders
22.50%
Institutions
9.33%
Public Float
12.03%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for PPSI

Yahoo Finance hu, 30 Jul 2026

Columbus McKinnon (CMCO) Q1 Earnings and Revenues Top Estimates

Columbus McKinnon (CMCO) delivered earnings and revenue surprises of +117.86% and +7.30%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo Finance ue, 23 Jun 2026

Q2 Investor Summit Virtual Live Wednesday June 24

NEW YORK, NY / ACCESS Newswire / June 23, 2026 / The Investor Summit today announced the lineup of public companies scheduled to present at its upcoming Virtual June 24-25, 2026 event. Event Details: Virtual Presentations on Wednesday June …

Yahoo Finance Mon, 18 May 2026

Pioneer Power Shares Drop After Q1 Earnings Miss Despite Revenue Beat (PPSI)

Stock Falls Following Quarterly ResultsShares of Pioneer Power Solutions (NASDAQ:PPSI) declined 6% in premarket trading on Monday after the company posted a wider-than-expected first-quarter loss, even as revenue came in above analyst forec…

Yahoo Finance ue, 12 May 2026

Hantavirus Outbreak Shows Need for Broad-Spectrum Antiviral Drugs

By Karen Roman NanoViricides, Inc. (NYSE: NNVC) said the recent outbreak of the hantavirus on a cruise ship highlights the need for broad-spectrum antiviral drugs such as NV-387. The hantavirus gets into the lungs through droplets of cough …

Yahoo Finance hu, 07 May 2026

NanoViricides to Participate at D. Boral Capital Global Conference in NYC

By Karen Roman NanoViricides, Inc. (NYSE: NNVC) said it will participate at the D. Boral Capital Global Conference, to be held on May 7, 2026, at The Plaza Hotel in New York City. The company’s President and Executive Chairman, Anil R. Diwa…

Yahoo Finance hu, 30 Apr 2026

Pioneer to Participate in the D. Boral Capital Global Conference 2026

Fort Lee, New Jersey--(Newsfile Corp. - April 30, 2026) - Pioneer Power Solutions, Inc. (NASDAQ: PPSI) ("Pioneer" or the "Company"), a leader in the design, manufacture, service and integration of distributed energy resources, power generat…

PPSI — Frequently Asked Questions

What is the current share price of PPSI?

As of 2026-08-05 17:25 PDT, PPSI trades at $3.05 on NASDAQ/NYSE. Its 52-week range is $2.37 to $6.08.

What is the market capitalisation of PPSI?

PPSI has a market capitalisation of $33.84M on NASDAQ/NYSE.

What is the P/E ratio of PPSI?

PPSI trades at a trailing price-to-earnings (P/E) ratio of -5.65. Its price-to-book (P/B) ratio is 1.15.

What is the return on equity (ROE) of PPSI?

PPSI has a return on equity (ROE) of -20.46%. Its return on capital employed (ROCE) is -21.57%.

Is PPSI a good stock to buy?

This page provides a data-driven analysis of PPSI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks